Detalles de la búsqueda
1.
Biomedical generative pre-trained based transformer language model for age-related disease target discovery.
Aging (Albany NY);
15(18): 9293-9309, 2023 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37742294
2.
A comprehensive AI-driven analysis of large-scale omic datasets reveals novel dual-purpose targets for the treatment of cancer and aging.
Aging Cell;
22(12): e14017, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37888486
3.
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine.
Aging (Albany NY);
14(6): 2475-2506, 2022 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35347083
4.
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics - An AI-Enabled Biological Target Discovery Platform.
Front Aging Neurosci;
14: 914017, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35837482
5.
TPI1-reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis.
J Extracell Vesicles;
10(10): e12135, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34401050
6.
Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells.
J Extracell Vesicles;
10(1): e12031, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33708358
7.
Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells.
J Exp Clin Cancer Res;
38(1): 423, 2019 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31640796
Resultados
1 -
7
de 7
1
Próxima >
>>